Curaleaf Holdings, Inc.
CURLF- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001756770
No open-market purchases or sales by Curaleaf Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $134.7M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Curaleaf Holdings, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 14 | 15 | +1 |
| Shares | 1.83M | 308.3K | −1.52M (−83.2%) |
| Value | $28.0M | $4.35M | −$23.7M (−84.5%) |
New holders (4)
Institutions that held Curaleaf Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Castleview Partners, LLC | 1,400 | $20.0K | 0.01% |
| FNY Investment Advisers, LLC | 900 | $12.0K | 0.00% |
| Tradition Wealth Management, LLC | 840 | $12.0K | 0.00% |
| Flagship Private Wealth, LLC | 150 | $2.08K | 0.00% |
Sold out (3)
Institutions that held Curaleaf Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Scopus Asset Management, L.P. | 1,550,000 | $23.8M |
| Boston Private Wealth LLC | 10,000 | $153.0K |
| Grant Street Asset Management, Inc. | 3,424 | $52.0K |